Last 70.15 INR
Change Today -0.70 / -0.99%
Volume 40.1K
As of 7:05 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

astec lifesciences ltd (ASTEL) Snapshot

Open
69.55
Previous Close
70.85
Day High
72.00
Day Low
69.50
52 Week High
09/10/14 - 79.95
52 Week Low
10/22/13 - 18.35
Market Cap
1.3B
Average Volume 10 Days
154.8K
EPS TTM
0.81
Shares Outstanding
18.5M
EX-Date
09/15/14
P/E TM
87.0x
Dividend
1.00
Dividend Yield
1.43%
Current Stock Chart for ASTEC LIFESCIENCES LTD (ASTEL)

Related News

No related news articles were found.

astec lifesciences ltd (ASTEL) Related Businessweek News

No Related Businessweek News Found

astec lifesciences ltd (ASTEL) Details

Astec LifeSciences Limited manufactures, sells, and exports agrochemicals and pharmaceutical intermediates in India. The company offers agrochemicals, such as tebuconazole, propiconazole, hexaconazole, difenoconazole, epoxiconazole, cyproconazole, flutriafol, tricyclazole, metalaxyl, lambda cyhalothrin, and imazethapyr; and pharmaceutical intermediates, including 2,4 dichloro acetophenone, 2-chloro and 4-fluoro acetophenone, 4-methyl phthalic anhydride, thio bis-4-chloro thymol, and 1,2-pentanediol. It also serves customers in the United States, Japan, Europe, and Asia. Astec LifeSciences Limited was founded in 1994 and is based in Mumbai, India.

Founded in 1994

astec lifesciences ltd (ASTEL) Top Compensated Officers

Chairman, Managing Director and Member of Ris...
Total Annual Compensation: 4.8M
Whole Time Director
Total Annual Compensation: 944.0K
Compensation as of Fiscal Year 2014.

astec lifesciences ltd (ASTEL) Key Developments

Astec Lifesciences Limited Reports Unaudited Consolidated and Standalone Earnings Results for the First Quarter Ended June 30, 2014

Astec LifeSciences Limited reported unaudited consolidated and standalone earnings results for the first quarter ended June 30, 2014. For the quarter, on standalone basis, the company reported total income from operations (net of excise duty) of INR 489.155 million compared to INR 416.425 million a year ago. Profit from operations before other income, interest & exceptional items was INR 55.023 million compared to INR 43.475 million a year ago. Profit from ordinary activities before tax was INR 31.390 million compared to INR 29.390 million a year ago. Net profit was INR 24.143 million or INR 1.30 per basic and diluted share compared to INR 20.273 million or INR 1.12 per basic and diluted share for the last year. For the quarter, on consolidated basis, the company reported total income from operations (net of excise duty) of INR 509.287 million compared to INR 422.615 million a year ago. Profit from operations before other income, interest & exceptional items was INR 51.897 million compared to INR 40.261 million a year ago. Profit from ordinary activities before tax was INR 25.320 million compared to INR 23.778 million a year ago. Net profit of INR 18.057 million or INR 0.97 per basic and diluted share compared to INR 14.653 million or INR 0.81 per basic and diluted share for the last year.

Astec Lifesciences Limited Approves Alternation of Memorandum of Association

Astec LifeSciences Limited announced that at the board of directors meeting held on August 9, 2014 approved alternation of memorandum of association and adopted new set of memorandum and articles of association.

Astec LifeSciences Limited to Report Q1, 2015 Results on Aug 05, 2014

Astec LifeSciences Limited announced that they will report Q1, 2015 results on Aug 05, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ASTEL:IN 70.15 INR -0.70

ASTEL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ASTEL.
View Industry Companies
 

Industry Analysis

ASTEL

Industry Average

Valuation ASTEL Industry Range
Price/Earnings 13.8x
Price/Sales 0.6x
Price/Book 1.1x
Price/Cash Flow 5.4x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTEC LIFESCIENCES LTD, please visit www.astecls.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.